S R Schreglmann
01.02.2018
Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - reply
Schreglmann S, Büchele F, Kägi G, Baumann C, study authors. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - reply. Eur J Neurol 2018; 25:e27-e28.
01.02.2018Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - reply
01.02.2018Eur J Neurol 2018; 25:e27-e28
Schreglmann S R, Büchele F, Kägi Georg, Baumann C R, study authors
Weiter
22.02.2017
Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial
Schreglmann S, Waldvogel D, Zimmerli L, Götze O, Hägele-Link S, Kägi G, Epprecht L, Sommerauer M, Büchele F, Baumann C. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial. Eur J Neurol 2017
22.02.2017Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial
22.02.2017Eur J Neurol 2017
Schreglmann S R, Waldvogel D, Zimmerli L, Götze O, Hägele-Link S, Kägi Georg, Epprecht L, Sommerauer M, Büchele F, Baumann C R
Weiter